459814-89-2

Basic information

• Product Name: (S)-5-(((4-((5-broMopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)Methyl)-5-MethyliMidazolidine-2,4-dione
• Synonyms: (S)-5-(((4-((5-broMopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)Methyl)-5-MethyliMidazolidine-2,4-dione;(S)-5-(((4-((5-Bromopyridin-2-yl)oxy)piperidin-1-yl)-sulfonyl)methyl)-5-methylimidazolidine-2,4-d;(S)-5-(((4-((5-Chloropyridin-2-yl)oxy)piperidin-1-yl)-sulfonyl)methyl)-5-methylimidazolidine-2
• CAS NO: 459814-89-2
• Molecular Formula: C15H19BrN4O5S
• Molecular Weight: 447.30416
• Mol File: 459814-89-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (S)-5-(((4-((5-broMopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)Methyl)-5-MethyliMidazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-5-(((4-((5-broMopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)Methyl)-5-MethyliMidazolidine-2,4-dione(459814-89-2)
• EPA Substance Registry System: (S)-5-(((4-((5-broMopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)Methyl)-5-MethyliMidazolidine-2,4-dione(459814-89-2)

Safety Data

• Hazardous Substances Data: 459814-89-2(Hazardous Substances Data)

Usage

General Description

"(S)-5-(((4-((5-Bromopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)methyl)-5-methylimidazolidine-2,4-dione" is a chemical compound that belongs to the class of imidazolidine-2,4-dione derivatives. (S)-5-(((4-((5-Bromopyridin-2-yl)oxy)piperidin-1-yl)sulfonyl)methyl)-5-methylimidazolidine-2,4-dione contains a sulfonyl group and a bromopyridin-2-yl moiety, making it a potential candidate for pharmaceutical applications. The presence of piperidine and imidazolidine rings in its structure suggests that it may have biological activity, possibly as a receptor or enzyme modulator. Further research is needed to determine its specific pharmacological properties and potential therapeutic uses.

Upstream product

• 260441-44-9 2-(4-piperidinyloxy)-5-chloropyridine 
• 459818-50-9 ((S)-4-methyl-2,5-dioxoimidazolidin-4-yl)methanesulfonyl chloride 

Relevant articles and documents

NOVEL CRYSTAL MODIFICATIONS

Novel crystal modifications of (5S)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonylmethyl]-5-methyl-imidazolidine-2,4-dione are disclosed together with processes for preparing such modifications, pharmaceutical compositions comprising such a modification, and the use of such a modification in therapy.